StonvexLoading…
StonvexStonvexStonvexCore line items from CTM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $14.29M | $52.87M | $40.31M | $25.69M |
Operating Income | $-698.00K | $-2.81M | $-1.42M | $-1.87M |
Net Income | $-351.27K | $-2.40M | $-1.08M | $-1.49M |
EPS (Diluted) | $0.00 | $-0.03 | $-0.01 | $-0.02 |
Total Assets | $41.82M | $41.90M | $46.25M | $43.45M |
Total Liabilities | $5.68M | $6.15M | $9.52M | $11.67M |
Cash & Equivalents | $15.77M | $14.88M | $17.82M | $14.73M |
Free Cash Flow OCF − CapEx | $1.28M | $-2.10M | $-1.43M | $-2.39M |
Shares Outstanding | 94.61M | 94.61M | 94.61M | 90.81M |